Collegium Pharmaceutical, Inc. COLL Jornay PM — 2027
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s jornay pm — 2027.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s jornay PM — 2027?
- Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — 2027 of $83.83M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s jornay PM — 2027 changed year-over-year?
- Collegium Pharmaceutical, Inc.'s jornay PM — 2027 decreased by 0.0% year-over-year, from $83.83M to $83.83M.
- What does jornay PM — 2027 mean?
- This represents the projected financial impact or specific asset-related value associated with a product for the calendar year 2027. It is used to track long-term amortization schedules or revenue expectations for strategic planning.